Edition:
United Kingdom

Aquestive Therapeutics Inc (AQST.OQ)

AQST.OQ on NASDAQ Stock Exchange Global Market

5.60USD
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
$5.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,992
52-wk High
$19.80
52-wk Low
$5.53

About

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of... (more)

Overall

Beta: --
Market Cap(Mil.): $--
Shares Outstanding(Mil.): 53.44
Dividend: --
Yield (%): --

Financials

  AQST.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -- -- --
ROI: -- 14.23 13.83
ROE: -- 15.46 15.25

FDA declines to approve Aquestive's Viagra rival

Aquestive Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its erectile dysfunction treatment and sought additional data.

16 Nov 2018

FDA declines to approve Aquestive's Viagra rival

Nov 16 Aquestive Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its erectile dysfunction treatment and sought additional data.

16 Nov 2018

Earnings vs. Estimates